BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28415774)

  • 1. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
    Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
    J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D; Auskalnis S; Skulcius G; Gudinaviciene I; Jievaltas M; Joniau S
    World J Urol; 2017 May; 35(5):721-728. PubMed ID: 27644229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research.
    Marshall JR
    IARC Sci Publ; 2001; 154():191-8. PubMed ID: 11220658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
    Mariani S; Lionetto L; Cavallari M; Tubaro A; Rasio D; De Nunzio C; Hong GM; Borro M; Simmaco M
    Int J Mol Sci; 2014 Jan; 15(1):1433-40. PubMed ID: 24451130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
    Alberts SR; Novotny PJ; Sloan JA; Danella J; Bostwick DG; Sebo TJ; Blute ML; Fitch TR; Levitt R; Lieberman R; Loprinzi CL
    Am J Ther; 2006; 13(4):291-7. PubMed ID: 16858161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
    Alberts SR; Blute ML
    Urology; 2001 Apr; 57(4 Suppl 1):188-90. PubMed ID: 11295624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic intraepithelial neoplasia: an update.
    Cheng L; Paterson RF; Beck SD; Parks J
    Clin Prostate Cancer; 2004 Jun; 3(1):26-30. PubMed ID: 15279687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
    Micali S; Territo A; Pirola GM; Ferrari N; Sighinolfi MC; Martorana E; Navarra M; Bianchi G
    Arch Ital Urol Androl; 2017 Oct; 89(3):197-202. PubMed ID: 28969404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis.
    Perletti G; Magri V; Vral A; Stamatiou K; Trinchieri A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.
    Sakr WA; Partin AW
    Urology; 2001 Apr; 57(4 Suppl 1):115-20. PubMed ID: 11295607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia.
    García-Cruz E; Piqueras M; Ribal MJ; Huguet J; Serapiao R; Peri L; Izquierdo L; Alcaraz A
    BJU Int; 2012 Sep; 110(6 Pt B):E199-202. PubMed ID: 22257176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Zhigang Z; Wenlu S
    Int J Cancer; 2008 Feb; 122(4):864-70. PubMed ID: 17957793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
    Xie W; Wong YC; Tsao SW
    Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.